Joshua Inglis

Joshua Inglis

Adelaide Medical School

Faculty of Health and Medical Sciences

I am a medical practitioner with experience in health services, academia and clinical trials. As a current PhD candidate in the area of pharmacology and multimorbidity, I have research experience in quality use of medicines, machine learning and the electronic health record. In addition to this, I am nearing the completion of dual training in Clinical Pharmacology and General Medicine with the Royal Australasian College of Physicians. I am also a HREC reviewer and investigator on multiple first-in-human oncology clinical trials.

Current Research Projects
Year Project Title Location
2022 - current Improving medication outcomes in older adults with multimorbidity University of Adelaide
2022 - current Evaluation of partnered pharmacist medication charting initiative and patient outcomes Flinders Medical Centre
2020 - current Implementation of inpatient penicillin allergy delabelling guided by machine learning Royal Adelaide Hospital
2022 - current Implementation of a hospital dashboard to enable proactive endocrine consultation Royal Adelaide Hospital

 

  • Appointments
    Date Position Institution name
    2022 - ongoing Clinical Pharmacology Registrar South Adelaide Local Health Network
    2022 - ongoing Clinical Trials Fellow Southern Oncology Clinical Research Unit
    2019 - ongoing Associate Clinical Lecturer University of Adelaide
    2018 - ongoing Associate Lecturer Flinders University

  • Awards and Achievements
    Date Type Title Institution Name Country Amount
    2021 Award Allan Kerr Grant Award in category of Outstanding Vocational Trainee Central Adelaide Local Health Network Australia -
    2016 Award Year 6 Award University of Adelaide Australia -
    2012 Award President’s Award Adelaide Medical Students’ Society Australia -

  • Education
    Date Institution name Country Title
    2016 Flinders University Australia Graduate Certificate in Clinical Education
    2011 - 2016 University of Adelaide Australia Bachelor of Medicine and Bachelor of Surgery

  • Research Interests
    Clinical Pharmacology and Therapeutics Clinical Trials General & Internal Medicine Public Health and Health Services

  • Journals
    Year Citation
    2025 Tan, J. Y., Ephraums, L. A., Inglis, J. M., Nguyen, H. T. T., Umapathysivam, M. M., Simpson, N. J., . . . Thynne, T. R. J. (2025). A Cross-Sectional Study of Capillary Blood Ketone Concentrations in Heart Failure Based on Sodium-Glucose Co-Transporter-2 Inhibitor Use and Heart Failure Type. Heart Lung and Circulation, 34(1), 34-39.
    DOI
    2025 Hurley, S. P., Horwood, C., Mallon, J., Mangoni, A. A., & Inglis, J. M. (2025). Characteristics of paracetamol poisoning in a local health network and consistency of hospital management with national guidelines. Internal Medicine Journal, 55(1), 139-142.
    DOI
    2024 Vitry, A., Inglis, J., & Caird, C. (2024). Evidence of clinical benefit of cancer medicines considered for funding in Australia. International Journal of Technology Assessment in Health Care, 40(1), e55.
    DOI
    2024 Inglis, J. M., Medlin, S., Bryant, K., Mangoni, A. A., & Phillips, C. J. (2024). The Clinical Impact of Hospital-Acquired Adverse Drug Reactions in Older Adults: An Australian Cohort Study. Journal of the American Medical Directors Association, 25(8), 9 pages.
    DOI Scopus1 Europe PMC1
    2024 Inglis, J. M., Caughey, G., Thynne, T., Brotherton, K., Liew, D., Mangoni, A. A., & Shakib, S. (2024). Inappropriate prescribing and association with readmission or mortality in hospitalised older adults with frailty: a systematic review and meta-analysis. BMC Geriatrics, 24(1), 18 pages.
    DOI
    2024 Jiang, M., Bacchi, S., Lam, L., Lam, A., Inglis, J. M., Gilbert, T., . . . Smith, W. (2024). Low-risk cefalexin allergies are associated with inpatient prescribing of second-line non-beta-lactam antibiotics. Allergo Journal International, 33(3), 73-79.
    DOI Scopus2
    2024 Lee, W. I., Lam, L., Bacchi, S., Jiang, M., Inglis, J. M., Smith, W., & Hissaria, P. (2024). Antibiotic prophylaxis in immunosuppressed patients – Missed opportunities from trimethoprim-sulfamethoxazole allergy label. World Allergy Organization Journal, 17(1), 14 pages.
    DOI Scopus1 Europe PMC1
    2024 Al Naji, H., Inglis, J. M., Tucker, E., Rowett, D., Larcombe, R., Medlin, S., . . . Thynne, T. (2024). Prescribing of antivirals for COVID-19 in a South Australian local health network according to statewide guidelines. Internal Medicine Journal, 54(1), 183-186.
    DOI
    2024 Stanekova, V., Inglis, J. M., Lam, L., Lam, A., Smith, W., Shakib, S., & Bacchi, S. (2024). Improving the performance of machine learning penicillin adverse drug reaction classification with synthetic data and transfer learning. Internal Medicine Journal, 54(7), 1183-1189.
    DOI
    2024 Umapathysivam, M. M., Morgan, B., Inglis, J. M., Meyer, E., Liew, D., Thiruvenkatarajan, V., & Jesudason, D. (2024). SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis. JAMA Network Open, 7(3), E242744.
    DOI Scopus2 Europe PMC1
    2024 Inglis, J. M., Caughey, G., Thynne, T., Brotherton, K., Liew, D., Mangoni, A. A., & Shakib, S. (2024). Association of Drug–Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. Drugs - Real World Outcomes, 11(3), 345-360.
    DOI
    2023 Inglis, J. M., Kichenadasse, G., & Mangoni, A. A. (2023). Current and emerging medications for the management of obesity in adults. Medical Journal of Australia, 219(4), 187.
    DOI Scopus1 WoS1
    2023 Inglis, J. M., Bacchi, S., Troelnikov, A., Smith, W., & Shakib, S. (2023). Machine learning models automate classification of penicillin adverse drug reaction labels. Internal Medicine Journal, 53(8), 1485-1488.
    DOI
    2023 Lam, L., Jiang, M., Bacchi, S., Kovoor, J., Inglis, J. M., Shakib, S., . . . Smith, W. (2023). Prevalence of Trimethoprim-Sulfamethoxazole Adverse Reaction Mislabelling in Australia. International Archives of Allergy and Immunology, 184(12), 1225-1229.
    DOI Scopus1
    2023 Inglis, J. M., & Mangoni, A. A. (2023). Protecting the heart. eLife, 12, 3 pages.
    DOI
    2023 Koopowitz, S. M., Arnold, M., Inglis, J. M., Hon, K., Vanlint, A., Koopowitz, L. F., & O'Callaghan, G. (2023). A community of practice to address system-based issues and promote clinical leadership among trainee medical officers in a large public health service: an evaluation of a trainee-led forum. Australian Health Review, 47(6), 667-670.
    DOI
    2023 Stretton, B., Jiang, M., Kovoor, J., Inglis, J. M., Lam, L., Tan, S., . . . Bacchi, S. (2023). Artificial intelligence–enabled penicillin allergy delabelling: an implementation study. Internal Medicine Journal, 53(11), 2119-2122.
    DOI Scopus3
    2023 Umapathysivam, M. M., Inglis, J. M., Morgan, B., Meyer, E., Thiruvenkatarajan, V., & Jesudason, D. (2023). Letter to the Editor: Response to Hamblin et al body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use. Clinical Endocrinology, 98(3), 449-451.
    DOI Scopus2 WoS1 Europe PMC1
    2023 Jiang, M., Bacchi, S., Lam, L., Inglis, J. M., Gluck, S., Smith, W., & Gilbert, T. (2023). Antibiotic Prescribing Practices Differ between Patients with Penicillin Intolerance and Penicillin Allergy Labels. International Archives of Allergy and Immunology, 184(2), 1-5.
    DOI Scopus6 WoS2
    2023 Thiruvenkatarajan, V., Inglis, J. M., Meyer, E., Umapathysivam, M. M., Nanjappa, N., Van Wijk, R., & Jesudason, D. (2023). Peri-colonoscopy Implications of Sodium-Glucose Cotransporter-2 Inhibitor Therapy: A Mini-review of Available Evidence. Canadian Journal of Diabetes, 47(3), 287-291.
    DOI Scopus1 Europe PMC1
    2023 Jiang, M., Lam, A., Lam, L., Kovoor, J., Inglis, J., Shakib, S., . . . Bacchi, S. (2023). Artificial intelligence and the potential for perioperative delabeling of penicillin allergies for neurosurgery inpatients. British Journal of Neurosurgery, 39(1), 40-43.
    DOI
    2023 Inglis, J. M., Yuson, C., & Smith, W. (2023). Recording and communicating opioid adverse drug reactions is an important element of opioid stewardship. Internal Medicine Journal, 53(3), 454.
    DOI Scopus1
    2022 Inglis, J. M., Furst, C., & Foreman, L. (2022). Noninvasive respiratory supports for the relief of terminal breathlessness. Current Opinion in Supportive and Palliative Care, 16(2), 78-82.
    DOI Scopus2 WoS1 Europe PMC1
    2021 Lambrecht, A., Inglis, J. M., & Young, R. (2021). Abdominal pain with intra-adrenal bleeding as an initial presentation of pheochromocytoma. BMJ Case Reports, 14(1), 4 pages.
    DOI Scopus1 WoS1 Europe PMC2
    2021 Inglis, J. M., Caughey, G. E., Smith, W., & Shakib, S. (2021). Documentation of Adverse Drug Reactions to Opioids in an Electronic Health Record.. Intern Med J, 51(9), 1490-1496.
    DOI Scopus7 WoS5 Europe PMC4
    2021 Inglis, J. M., Bacchi, S., Troelnikov, A., Smith, W., & Shakib, S. (2021). Automation of penicillin adverse drug reaction categorisation and risk stratification with machine learning natural language processing. International Journal of Medical Informatics, 156, 104611-1-104611-5.
    DOI Scopus18 WoS6 Europe PMC5
    2020 Foreman, C., Le, T. T. A., Inglis, J. M., & Smith, W. B. (2020). Penicillin allergy labeling on medical alert jewelry. Annals of Allergy, Asthma and Immunology, 124(6), 627-629.
    DOI Scopus1 WoS1
    2020 Inglis, J. M., & Tan, J. (2020). Scurvy presenting as lower limb ecchymoses in the setting of metastatic colorectal cancer. BMJ Case Reports, 13(12), 4 pages.
    DOI Scopus1 WoS1 Europe PMC1
    2019 Inglis, J. M., Caughey, G. E., & Shakib, S. (2019). Use of non-formulary high-cost medicines in an Australian public hospital. International Journal of Clinical Pharmacy, 41(4), 920-931.
    DOI Scopus6 WoS5 Europe PMC5
    2019 Caughey, G. E., Shakib, S., Inglis, J. M., Le, T. T., Yuson, C. L., & Smith, W. B. (2019). External validation of beta-lactam antibiotic allergy assessment tools: implications for clinical practice and workforce capacity. Journal of Allergy and Clinical Immunology: In Practice, 7(6), 2094-2095.
    DOI Scopus5 WoS3 Europe PMC1
    2018 Inglis, J. M., Barbara, J. A., Juneja, R., Milton, C., Passaris, G., & Li, J. Y. Z. (2018). Atypical Haemolytic Uraemic Syndrome Associated with <i>Clostridium difficile</i> Infection Successfully Treated with Eculizumab.. Case reports in nephrology, 2018, 1759138.
    DOI Europe PMC3
    2018 Inglis, J. M., & Wood, N. K. (2018). Breaking the routine of peripheral venous catheter replacement. Internal Medicine Journal, 48(5), 606.
    DOI Scopus1 Europe PMC1
    2017 Inglis, J., Caughey, G., Smith, W., & Shakib, S. (2017). Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labels. Internal Medicine Journal, 47(11), 1292-1297.
    DOI Scopus66 WoS50 Europe PMC26
    2016 Kremer, K., Smith, A., Sandeman, L., Inglis, J., Ridding, M., & Koblar, S. (2016). Transcranial magnetic stimulation of human adult stem cells in the mammalian brain. Frontiers in Neural Circuits, 10(MAR), 17-1-17-9.
    DOI Scopus10 WoS8 Europe PMC5

  • Preprint
    Year Citation
    2022 Trigg, J., Shen, D., Morris, J., & Blunt, J. (2022). Characteristics of Aboriginal and Torres Strait Islander Smokers Exposed to Anti-smoking Marketing in South Australia.
    DOI
Current Grants and Funding

Bacchi S (CIA), Smith W (CIB), Shakib S (CIC), Inglis J (CID). Electronic Penicillin Allergy Screening with Machine Learning (EPAS-ML) with Systematic Allergy Delabelling. Clinical Rapid Implementation Project Scheme 2023-2025, Central Adelaide Local Health Network. $200,000.

Teaching Activities
Year Project Title Location
2021 - current RACP Clinical Trials Examiner Statewide
2022 - current Cognitive Bias and Diagnostic Errors Lecture Lyell McEwin Hospital
2017 - 2021

Year 3 Bedside Clinical Tutor

 University of Adelaide
2018 - 2021 Year 2-3 Clinical Skills Assessor University of Adelaide
2020 Year 6 Learning Coach University of Adelaide

  • Committee Memberships
    Date Role Committee Institution Country
    2022 - ongoing Member Human Research Ethics Committee Southern Adelaide Local Health Network Australia

  • Memberships
    Date Role Membership Country
    2022 - ongoing Representative Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Australia
    2022 - ongoing Member Toxicology and Poisons Network Australasia Australia
    2021 - ongoing Member SA Association of Internal Medicine Australia
    2020 - ongoing Member Society to Improve Diagnosis in Medicine Australia

  • Consulting/Advisories
    Date Institution Department Organisation Type Country
    2022 - ongoing Australian Medicines Handbook - Health services and related Australia
Connect With Me
External Profiles